Anzeige
Mehr »
Login
Dienstag, 27.07.2021 Börsentäglich über 12.000 News von 669 internationalen Medien
Setzt jetzt der Dollar-Regen ein? Die Transformation zur sprudelnden Gold-Quelle!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QQJB ISIN: US52886N4060 Ticker-Symbol:  
NASDAQ
26.07.21
22:00 Uhr
6,770 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
LEXARIA BIOSCIENCE CORP Chart 1 Jahr
5-Tage-Chart
LEXARIA BIOSCIENCE CORP 5-Tage-Chart

Aktuelle News zur LEXARIA BIOSCIENCE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
13:20Lexaria Bioscience Corp.: Lexaria Completes Dosing in Human Clinical Study HYPER-H21-211Additionally, second patent award received in JapanKELOWNA, BC / ACCESSWIRE / July 27, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in...
► Artikel lesen
LEXARIA BIOSCIENCE Aktie jetzt für 0€ handeln
MoLexaria Receives US$3,817,643 From Warrant Exercises-
MoLexaria Bioscience Corp.: Lexaria Receives US$3,817,643 From Warrant Exercises187KELOWNA, BC / ACCESSWIRE / July 26, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce the...
► Artikel lesen
DoLexaria Hits New 52-Week High With Positive Data On Enhanced Treatment For COVID-192
DoDomino's Pizza and Zovio among consumer gainers; Lexaria Bioscience among losers3
DoLexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy2
DoLexaria Bioscience Corp.: Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy172All objectives evaluating DehydraTECH drug delivery platform successfully achievedKELOWNA, BC / ACCESSWIRE / July 22, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria")...
► Artikel lesen
MiLexaria Bioscience leads consumer gainers; Autohome and Harley-Davidson among losers6
MiLexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-32
MiLexaria climbs on performance of drug delivery system for COVID-19 therapy in mice study1
MiLexaria Bioscience Corp.: Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3159Possible Benefits for Treating SARS-CoV-2/COVID-19 and mRNA Vaccine Side EffectsKELOWNA, BC / ACCESSWIRE / July 21, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria")...
► Artikel lesen
15.07.Lexaria Bioscience Corp. - 10-Q, Quaterly Report-
15.07.Lexaria Shares Are Trading Higher On Completion Of Antiviral Drug Molecular Characterization Study-
15.07.Lexaria Completes Successful Antiviral Drug Molecular Characterization Study with Canada's National Research Council-
15.07.Lexaria Bioscience Corp.: Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council140VIRAL-MC21-1 Demonstrates Stability of DehydraTECH-Enabled Antiviral DrugsKELOWNA, BC / ACCESSWIRE / July 15, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria")...
► Artikel lesen
13.07.Lexaria Receives Patent Protection in Japan1
13.07.Lexaria Bioscience Corp.: Lexaria Receives Patent Protection in Japan1.135New patent granted in Japan adds to existing patents in the EU, the U.S., India and AustraliaKELOWNA, BC / ACCESSWIRE / July 13, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company"...
► Artikel lesen
08.07.Lexaria Bioscience Corp (2): Lexaria Bioscience to be delisted from CSE July 81
08.07.CSE Bulletin: Delist - Lexaria Bioscience Corp. (LXX)196Toronto, Ontario--(Newsfile Corp. - le 8 juillet/July 2021) At the request of the company the common shares of Lexaria Bioscience Corp. will be delisted at market close on July 8, 2021. The...
► Artikel lesen
06.07.Lexaria Bioscience Corp. - 8-K, Current Report-
Seite:  Weiter >>
132 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1